Alogliptin Benzoate
Therapeutic Category
- Anti-diabetic
Innovator Brand
GMP
DMF
Filed
Under Filing
Sample
Indication
Alogliptin is indicated for use as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It can be used as monotherapy or in combination with other antidiabetic medications, including metformin, sulfonylureas, thiazolidinediones, or insulin.
CTX Lifesciences, is one of the leading Active Pharmaceutical Ingredients ( API ) manufacturer and supplier globally for Alogliptin Benzoate API with Cas #850649-62-6. We are a leading exporter of Alogliptin Benzoate API with Cas #850649-62-6. We are a trusted supplier with API exports in more than 87 Countries including the US, Europe, Brazil, Latin America, China, Korea, Middle East and other emerging markets.
CTX Lifesciences is one of the leading API manufacturer & supplier of Alogliptin Benzoate API with Cas #850649-62-6. This product is provided from our GMP compliant plant with product made under complete cGMP conditions. We provided with documentation support Drug Master File ( DMF ). Our manufacturing plant at Surat has accreditation by US-FDA, EDQM, EMA, ANVISA, KFDA, Health Canada & Russian Authorities.
CTX supplies multiple pharmacopeial grades of its APIs, each tailored to customer requirements. Every product comes with a complete Drug Master File (DMF) to support regulatory submissions to global health authorities.
To ensure reliable quality, CTX maintains full backward integration. We manufacture key starting materials and intermediates in-house, giving us greater control over quality, supply consistency, and traceability. This approach also allows us to scale production quickly whenever customers face sudden demand spikes.
Our APIs deliver uniform performance batch after batch. We tightly control polymorphic form, impurity profile, particle size distribution, and stability parameters. Each product contains very low nitrosamine levels and undergoes a thorough assessment for genotoxic impurities, ensuring high purity and global regulatory compliance.
Sustainability and safety guide our operations from end to end. CTX runs in-house ETP, MEE, and ATFD systems to manage all effluents responsibly and meet every environmental requirement set by government authorities.
CTX also offers other Dipeptidyl peptidase-4( DDP-4 ) inhibitor as mentioned below. Please check them out below.
CTX also offers Sodium/glucose cotransporter 2 inhibitors (also called gliflozins or flozins) , a class of medications that inhibit sodium-glucose transport proteins in the nephron (the functional units of the kidney). Please check them below.
It also offers an oxidative phosphorylation blocker i.e Imeglimin Hydrochloride
Disclaimer: CTX Lifesciences respects patent laws and conventions of pharmaceuticals as applicable in different countries.
API/Substances covered by patent are not offered to the countries where the patent law is in force. However, the final responsibility lies with the customer.